Terms: = Testicular cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1
35 results:
1. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S
Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580
[TBL] [Abstract] [Full Text] [Related]
2. Frequent expression of CD45RO memory T cell marker as well as low to high expression of pd-1 and PD-L1 inhibitory molecules in seminoma and dysgerminoma.
Farahani H; Dehghanian AR; Khademolhosseini A; Haghshenas MR; Erfani N
J Reprod Immunol; 2024 Feb; 161():104184. PubMed ID: 38171036
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies.
Meng J; Gao J; Li X; Gao R; Lu X; Zhou J; Yan F; Wang H; Liu Y; Hao Z; Zhang X; Liang C
Cell Oncol (Dordr); 2023 Jun; 46(3):745-759. PubMed ID: 36823338
[TBL] [Abstract] [Full Text] [Related]
5. Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.
Zhang H; Jiang D; Meng E; Zhao M; Niu B
Immunotherapy; 2023 Jan; 15(1):17-25. PubMed ID: 36647794
[TBL] [Abstract] [Full Text] [Related]
6. Cutaneous Melanoma and Hormones: Focus on Sex Differences and the Testis.
Cosci I; Grande G; Di Nisio A; Rocca MS; Del Fiore P; Benna C; Mocellin S; Ferlin A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614041
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies.
Giampietri C; Scatozza F; Crecca E; Vigiano Benedetti V; Natali PG; Facchiano A
J Transl Med; 2022 Oct; 20(1):467. PubMed ID: 36224560
[TBL] [Abstract] [Full Text] [Related]
8. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of cancers: A Pan-cancer Analysis.
Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
Front Immunol; 2022; 13():844736. PubMed ID: 35592314
[TBL] [Abstract] [Full Text] [Related]
9. Promising Immunotherapy in Metastatic testicular Sex Cord Stromal Tumours After First-Line Chemotherapy.
Shang B; Cao C; Jiang W; Shi H; Bi X; Cui C; Shou J; Zheng S; Zhang J; Zhou A; Li C; Ma J
Front Immunol; 2021; 12():720359. PubMed ID: 35082775
[TBL] [Abstract] [Full Text] [Related]
10. Pan-cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract] [Full Text] [Related]
11. Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors.
Al-Hogbani M; Duguay J; Wagner DC; Haferkamp A; Joubert P; Frees S; Rendon R; Power N; Périgny M; Toren P
Urol Oncol; 2021 May; 39(5):303.e1-303.e8. PubMed ID: 33685799
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
Ji YS; Park SH
Cancer Res Treat; 2021 Jul; 53(3):874-880. PubMed ID: 33285049
[TBL] [Abstract] [Full Text] [Related]
13. Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma.
Pollari M; Pellinen T; Karjalainen-Lindsberg ML; Kellokumpu-Lehtinen PL; Leivonen SK; Leppä S
Eur J Haematol; 2020 Dec; 105(6):712-721. PubMed ID: 32632935
[TBL] [Abstract] [Full Text] [Related]
14. The immunotherapy revolution in genitourinary malignancies.
U Gandhy S; Madan RA; Aragon-Ching JB
Immunotherapy; 2020 Aug; 12(11):819-831. PubMed ID: 32594815
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.
Zhu MMT; Burugu S; Gao D; Yu J; Kos Z; Leung S; Horst BA; Nielsen TO
Mod Pathol; 2020 Sep; 33(9):1753-1763. PubMed ID: 32350416
[TBL] [Abstract] [Full Text] [Related]
16. pd1/PD-L1 Axis in Uro-oncology.
Junker K; Eckstein M; Fiorentino M; Montironi R
Curr Drug Targets; 2020; 21(13):1293-1300. PubMed ID: 32213156
[TBL] [Abstract] [Full Text] [Related]
17. Differences in PD-L1-Expressing Macrophages and Immune Microenvironment in testicular Germ Cell Tumors.
Sadigh S; Farahani SJ; Shah A; Vaughn D; Lal P
Am J Clin Pathol; 2020 Feb; 153(3):387-395. PubMed ID: 31802108
[TBL] [Abstract] [Full Text] [Related]
18. Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
Wang Y; Wenzl K; Manske MK; Asmann YW; Sarangi V; Greipp PT; Krull JE; Hartert K; He R; Feldman AL; Maurer MJ; Slager SL; Nowakowski GS; Habermann TM; Witzig TE; Link BK; Ansell SM; Cerhan JR; Novak AJ
Blood Cancer J; 2019 Aug; 9(9):73. PubMed ID: 31471540
[TBL] [Abstract] [Full Text] [Related]
19. Immune mechanisms and possible immune therapy in testicular germ cell tumours.
Chovanec M; Mardiak J; Mego M
Andrology; 2019 Jul; 7(4):479-486. PubMed ID: 31169364
[TBL] [Abstract] [Full Text] [Related]
20. Severe Epididymo-Orchitis and Encephalitis Complicating Anti-pd-1 Therapy.
Quach HT; Robbins CJ; Balko JM; Chiu CY; Miller S; Wilson MR; Nelson GE; Johnson DB
Oncologist; 2019 Jul; 24(7):872-876. PubMed ID: 30936376
[TBL] [Abstract] [Full Text] [Related]
[Next]
